Surgery Partners (NASDAQ:SGRY) Sets New 12-Month Low – Here’s What Happened

Surgery Partners, Inc. (NASDAQ:SGRY) hit a new 52-week low during trading on Monday . The stock traded as low as $22.04 and last traded at $22.17, with a volume of 1715635 shares. The stock had previously closed at $22.95.

Analyst Ratings Changes

A number of equities research analysts recently weighed in on the company. Cantor Fitzgerald restated an “overweight” rating and issued a $43.00 price target on shares of Surgery Partners in a research note on Friday, October 4th. KeyCorp started coverage on shares of Surgery Partners in a research note on Friday, October 11th. They issued a “sector weight” rating on the stock. Benchmark reissued a “buy” rating and issued a $50.00 price target on shares of Surgery Partners in a report on Monday, August 26th. UBS Group assumed coverage on Surgery Partners in a research report on Monday, October 14th. They issued a “buy” rating and a $38.00 target price on the stock. Finally, Royal Bank of Canada reiterated an “outperform” rating and set a $49.00 target price on shares of Surgery Partners in a research note on Wednesday, August 7th. One investment analyst has rated the stock with a sell rating, two have given a hold rating and six have given a buy rating to the company. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $40.71.

Surgery Partners Trading Down 4.9 %

The company has a debt-to-equity ratio of 0.99, a quick ratio of 1.69 and a current ratio of 1.80. The company has a market capitalization of $2.77 billion, a price-to-earnings ratio of -47.48, a price-to-earnings-growth ratio of 16.86 and a beta of 2.76. The firm has a fifty day moving average price of $30.62 and a 200-day moving average price of $28.48.

Surgery Partners (NASDAQ:SGRY) last released its earnings results on Tuesday, November 12th. The company reported $0.19 EPS for the quarter, missing the consensus estimate of $0.25 by ($0.06). Surgery Partners had a negative net margin of 2.03% and a positive return on equity of 2.85%. The firm had revenue of $770.40 million during the quarter, compared to the consensus estimate of $768.99 million. During the same period in the prior year, the business earned $0.15 earnings per share. Surgery Partners’s quarterly revenue was up 14.3% compared to the same quarter last year. As a group, equities analysts anticipate that Surgery Partners, Inc. will post 0.83 EPS for the current year.

Institutional Investors Weigh In On Surgery Partners

A number of large investors have recently modified their holdings of the business. Quarry LP raised its holdings in shares of Surgery Partners by 133.1% during the 2nd quarter. Quarry LP now owns 3,082 shares of the company’s stock worth $73,000 after buying an additional 1,760 shares in the last quarter. KBC Group NV grew its position in Surgery Partners by 31.8% in the third quarter. KBC Group NV now owns 2,385 shares of the company’s stock valued at $77,000 after acquiring an additional 576 shares during the last quarter. DekaBank Deutsche Girozentrale raised its stake in Surgery Partners by 102.0% during the first quarter. DekaBank Deutsche Girozentrale now owns 2,723 shares of the company’s stock worth $80,000 after acquiring an additional 1,375 shares in the last quarter. Point72 Asia Singapore Pte. Ltd. lifted its holdings in shares of Surgery Partners by 747.6% in the third quarter. Point72 Asia Singapore Pte. Ltd. now owns 3,831 shares of the company’s stock worth $124,000 after acquiring an additional 3,379 shares during the last quarter. Finally, EntryPoint Capital LLC lifted its holdings in shares of Surgery Partners by 257.1% in the first quarter. EntryPoint Capital LLC now owns 6,399 shares of the company’s stock worth $191,000 after acquiring an additional 4,607 shares during the last quarter.

Surgery Partners Company Profile

Surgery Partners, Inc, together with its subsidiaries, owns and operates a network of surgical facilities and ancillary services in the United States. The company provides ambulatory surgery centers and surgical hospitals that offer non-emergency surgical procedures in various specialties, including orthopedics and pain management, ophthalmology, gastroenterology, and general surgery.